Shenzhen Salubris Pharmaceuticals Co., Ltd.
Clinical trials sponsored by Shenzhen Salubris Pharmaceuticals Co., Ltd., explained in plain language.
-
New cholesterol drug shows promise in major trial
Disease control CompletedThis study tested a new injectable drug called SAL003 for people with high cholesterol. Over 600 participants received either the drug or a placebo shot every four weeks for 12 weeks. The main goal was to see if SAL003 was better than a placebo at lowering 'bad' LDL cholesterol. …
Phase: PHASE3 • Sponsor: Shenzhen Salubris Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
New injection aims to tackle stubborn high cholesterol
Disease control CompletedThis study tested whether adding a new injectable drug called SAL003 to standard cholesterol pills (atorvastatin) could better lower 'bad' cholesterol (LDL-C) in adults with high cholesterol. It involved 214 participants and compared the effects of the new injection to a placebo …
Phase: PHASE2 • Sponsor: Shenzhen Salubris Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
Breakthrough injection cuts bad cholesterol when pills Aren't enough
Disease control CompletedThis study tested whether adding a new injection called SAL003 to standard cholesterol pills helps lower bad cholesterol more effectively. The trial involved 720 Chinese adults with high cholesterol who weren't reaching target levels despite taking their regular medication. Parti…
Phase: PHASE3 • Sponsor: Shenzhen Salubris Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC